BibbInstruments AB (BIBB) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of BibbInstruments AB stock SEK 0.27, price SEK 0.35, that is 21.9% below the price, quality 34 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
BibbInstruments AB
BIBB · STExpensive (fair value 22% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range kr 0.3430 – kr 10.60 · fair‑value band kr 0.2032 – kr 0.3386 · the kr 0.3470 price screens above the kr 0.2709 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether BibbInstruments is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
BiBBInstruments AB, a medical technology company, develops and markets electrically powered endoscopic biopsy systems in the United States and Europe.
Show moreShow less
The company offers EndoDrill which enables tissue sampling, with the aim of improving diagnostics in several common cancers, including those affecting the pancreas, stomach, liver, lungs, and urinary bladder.
It also provides EndoDrill GI which used for endoscopic ultrasound; EndoDrill EBUS is used in the airways during endobronchial ultrasound (EBUS); and EndoDrill URO that is used with a standard cystoscope for sampling of muscle-invasive bladder cancer.
The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Stock analysis
BibbInstruments AB (BIBB) currently trades at kr 0.3470, while our estimate is kr 0.2709, 22% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: kr 0.2032 (bear) to kr 0.3386 (bull), the price of kr 0.3470 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
BibbInstruments AB reported revenue of 401K SEK in FY2025 versus 0 SEK in FY2022. Reported net income was −14.6M SEK in FY2025.
Key figures
Market cap 57.2M SEK (≈ $5.7M) Micro · P/S ratio 67.8 · EPS (TTM) kr −0.2600 · Return on equity −33.3% · Return on assets (EBIT) −35.1% (4-year average) · Operating margin −1,194% · Revenue (TTM) 947K SEK · Revenue growth (YoY) +192%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 7 out of 100 (medium confidence).
What moves the price
The share trades about 91% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −22%, BIBB screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
BIBB screens overvalued: fair value 22% below the price. Compare with Abbott Laboratories, →
Compare BibbInstruments AB with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- Stock screener with 62 metrics
- Valuation of the Sweden market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs BIBB |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs BIBB |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs BIBB |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥184.30 | ¥197.34 | +7% | vs BIBB |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs BIBB |
| Siemens Healthineers AG SHL | €44.00 | €34.51 | −22% | vs BIBB |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs BIBB |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs BIBB |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs BIBB |
| Koninklijke Philips N.V PHIA | €27.54 | €15.23 | −45% | vs BIBB |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is BibbInstruments AB (BIBB) overvalued or undervalued?
What is the fair value of BIBB?
What is the quality score of BIBB?
What is the price target for BibbInstruments AB (BIBB)?
What is the BibbInstruments AB stock forecast for 2026?
What is the revenue of BibbInstruments AB (BIBB)?
What is the intrinsic value of BibbInstruments AB (BIBB)?
Is BibbInstruments AB stock overvalued or undervalued in 2026?
Is fair value the same as the market price of BIBB?
How much is BibbInstruments AB worth?
What do the bullish and bearish scenarios say about BIBB?
How solid is the balance sheet of BibbInstruments AB (BIBB)?
How far is BIBB from its 52-week high?
Which stocks are comparable to BibbInstruments AB?
Is BibbInstruments AB stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of BibbInstruments AB (BIBB)?
What should I pay attention to with BibbInstruments AB right now?
Key figures of BibbInstruments AB
How large is the market capitalisation of BibbInstruments AB (BIBB)?
What is the P/S ratio of BibbInstruments AB (BIBB)?
What are the earnings per share of BibbInstruments AB (BIBB)?
What is the return on equity of BibbInstruments AB (BIBB)?
What is the EBIT return on assets of BibbInstruments AB (BIBB)?
What is the operating margin of BibbInstruments AB (BIBB)?
How fast is revenue growing at BibbInstruments AB (BIBB)?
How much free cash flow does BibbInstruments AB (BIBB) generate?
Watch BibbInstruments AB in the live analysis
One click puts BibbInstruments AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.